clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2023-101-11-212-229clinmed-782Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESДиагностика и лечение внебольничной пневмонии у военнослужащих (методические указания)Diagnosis and treatment of community-acquired pneumonia in military personnel (Guidelines)ЗайцевА. А.ZaitsevA. A.

Зайцев Андрей Алексеевич — д-р мед. наук, профессор, главный пульмонолог Минобороны России

Москва

Andrey A. Zaitsev — Dr of Sci. (Med.), Professor, Chief Pulmonologist of the Ministry of Defense of Russia

Moscow

a-zaicev-a@yandex.ruМакаревичА. М.MakarevichA. M.

Макаревич Андрей Михайлович — канд. мед. наук, заместитель начальника

Хабаровск

Andrey M. Makarevich – Cand. of Sci. (Med.), Deputy Chief of the Federal State Budgetary Institution

Khabarovsk

ПаценкоМ. Б.PatsenkoM. B.

Паценко Михаил Борисович — д-р. мед. наук, доцент, главный терапевт Минобороны России, начальник кафедры терапии неотложных состояний филиала ВМА им. С.М. Кирова в г. Москве 

Москва

Mikhail B. Patsenko — Dr. of Sci. (Med.), Associate Professor, Chief Therapist of the Ministry of Defense of Russia, Head of the Department of Emergency Therapy at the Branch of the S.M. Kirov Military Medical Academy in Moscow

Moscow

СинопальниковА. И.SinopalnikovA. I.

Синопальников Александр Игоревич — д-р мед. наук, профессор, заведующий кафедрой пульмонологии 

Москва

Alexander I. Sinopalnikov — Dr of Sci. (Med.), Professor, Head of the Pulmonology Department of the Federal State Budgetary Educational Institution for Advanced Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of Russia

Moscow

СерговенцевА. А.SergoventsevA. A.

Серговенцев Александр Александрович — канд. мед. наук, заместитель начальника 

Москва

Alexander A. Sergoventsev — Cand. of Sci. (Med.), Deputy Chief 

Moscow

КрюковЕ. В.KryukovE. V.

Крюков Евгений Владимирович — д-р мед. наук, профессор, академик РАН, начальник

Санкт-Петербург

Evgeny V. Kryukov — Dr of Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head

Saint Petersburg

ФГБУ «Главный военный клинический госпиталь им. академика Н.Н. Бурденко» Минобороны РоссииРоссияMain Military Clinical Hospital named after Academician N.N. Burdenko of the Ministry of Defense of RussiaRussian FederationФГКУ «301 военный клинический госпиталь» Минобороны РоссииРоссия301 Military Clinical Hospital of the Ministry of Defense of RussiaRussian FederationГлавное военно-медицинское управление Минобороны РоссииРоссияMain Military Medical Directorate of the Ministry of Defense of RussiaRussian FederationФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of RussiaRussian FederationФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Минобороны РоссииРоссияMilitary Medical Academy named after S.M. Kirov of the Ministry of Defense of RussiaRussian Federation2024010620241023212229Copyright © Зайцев А.А., Макаревич А.М., Паценко М.Б., Синопальников А.И., Серговенцев А.А., Крюков Е.В., 20242024Зайцев А.А., Макаревич А.М., Паценко М.Б., Синопальников А.И., Серговенцев А.А., Крюков Е.В.Zaitsev A.A., Makarevich A.M., Patsenko M.B., Sinopalnikov A.I., Sergoventsev A.A., Kryukov E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/782

Внебольничная пневмония является актуальной проблемой для медицинской службы Вооруженных Сил Российской Федерации. В статье приводятся основные положения современных клинических указаний по ведению больных с внебольничной пневмонией. Представлены возможности диагностики, шкалы определения прогноза заболевания, критерии направления пациентов в отделения реанимации и интенсивной терапии, режимы назначения антибиотиков и пр. Указания должны использоваться в процессе подготовки военных врачей и в служебной деятельности медицинских работников всех звеньев медицинской службы.

Community-acquired pneumonia is a relevant issue for the medical service of the Armed Forces of the Russian Federation. The article presents the main points of modern clinical guidelines for managing patients with community-acquired pneumonia. It discusses diagnostic possibilities, prognostic scoring systems, criteria for transferring patients to intensive care units, antibiotic prescribing regimens, etc. These guidelines should be used in the training of military doctors and in the professional activities of healthcare workers at all levels of the medical service.

внебольничная пневмонияантимикробная терапиявоеннослужащиеиндикаторы качества оказания помощиcommunity-acquired pneumoniaantimicrobial therapymilitary personnelquality indicators of careReferencesАвдеев С.Н., Дехнич А.В., Зайцев А.А. и др. Внебольничная пневмония: федеральные клинические рекомендации по диагностике и лечению. Пульмонология. 2022;32(3):295–355.Avdeev S.N., Dekhnich A.V., Zaitsev A.A. et al. Communityacquired pneumonia: federal clinical guidelines for diagnosis and treatment. Pulmonology. 2022;32(3):295–355. (In Russian).Авдеев С.Н., Белобородов В.Б., Белоцерковский Б.З. Тяжелая внебольничная пневмония у взрослых. Клинические рекомендации Федерации анестезиологов и реаниматологов России. Анестезиология и реаниматология. 2022;1:6–35.Avdeev S.N., Beloborodov V.B., Belotserkovsky B.Z. Severe community–acquired pneumonia in adults. Clinical recommendations of the Federation of anesthesiologists and resuscitators of Russia. Anesthesiology and resuscitation. 2022;1:6–35. (In Russian).Авдеев С.Н., Зайцев А.А., Жданов К.В. и др. Алгоритмы ведения пациентов с тяжелыми формами гриппа А/H1N1: от диагностики до методов респираторной поддержки. Методические рекомендации. Consilium Medicum. 2022;24(12):843–850.Avdeev S.N., Zaitsev A.A., Zhdanov K.V. et al. Algorithms for managing patients with severe forms of infl uenza A. H1N1: from diagnostics to methods of respiratory support. Guidelines. Consilium Medicum. 2022;24(12):843–850. (In Russian).Гайдук С.В., Овчинников Ю.В., Халимов Ю.Ш., Гайдук В.А. Кардио-респираторная патология у раненых в контртеррористической операции в Чеченской Республике. Вестник Российской Военно-медицинской академии. 2016;1(53):22–28.Gaiduk S.V., Ovchinnikov Yu.V., Khalimov Yu.Sh., Gaiduk V.A. Cardio-respiratory pathology in the wounded in the counter-terrorist operation in the Chechen Republic. Bulletin of the Russian Military Medical Academy. 2016;1 (53):22–28. (In Russian).Зайцев А.А. Эпидемиология заболеваний органов дыхания у военнослужащих и направления по совершенствованию пульмонологической помощи. Военно-медицинский журнал. 2018;11:4–9.Zaitsev A.A. Epidemiology of respiratory diseases in military personnel and directions for improving pulmonological care. Military Medical Journal. 2018;11:4–9. (In Russian).Зайцев А.А., Макаревич А.М., Паценко М.Б., Серговенцев А.А. Ошибки ведения больных с внебольничной пневмонией. Военно-медицинский журнал. 2022;343(12):24–37.Zaitsev A.A., Makarevich A.M., Patsenko M.B., Sergoventsev A.A. Errors in the management of patients with community-acquired pneumonia. Military Medical Journal. 2022;343(12):24–37. (In Russian).Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Биологические маркеры воспаления при внебольничной пневмонии. Consilium Medicum. 2014;16(11):36–41.Zaitsev A.A., Ovchinnikov Yu.V., Kon dratieva T.V. Biological markers of inflammation in communityac quired pneumonia. Consilium Medicum. 2014;16(11):36–41. (In Russian).Зайцев А.А., Овчинников Ю.В., Чернов С.А., Кондратьева Т.В. Применение шкал оценки тяжести состояния больных внебольничной пневмонией у пациентов молодого возраста. Военно-медицинский журнал. 2014;335(3):31–38.Zaitsev A.A., Ovchinnikov Yu.V., Chernov S.A., Kondratieva T.V. Application of scales for assessing the severity of the condition of patients with community–acquired pneumonia in young patients. Military Medical Journal. 2014;335(3):31–38. (In Russian).Зайцев А.А., Щёголев А.В. Диагностика и лечение тяжелых поражений легких при гриппе А(H1N1/09): практические рекомендации. Военно-медицинский журнал. 2016;337(3)39–46.Zaitsev A.A., Shchegolev A.V. Diagnosis and treatment of severe lung lesions in influenza A (H1N1. 09): practical recommendations. Military Medical Journal. 2016;337(3)39–46. (In Russian).Захаренков И.А., Рачина С.А., Дехнич Н.Н. и др. Этиология тяжелой внебольничной пневмонии у взрослых: результаты первого россий ского многоцентрового исследования. Терапевтический архив. 2020;92(1):36–42.Zakharenkov I.A., Rachina S.A., Dekhnich N.N. Etiology of severe communityacquired pneumonia in adults: results of the first Russian multicenter study. Therapeutic archive. 2020;92(1):36–42. (In Russian).Кучмин А.Н., Акимкин В.Г., Синопальников А.И. и др. Диагностика, лечение и профилактика внебольничной пневмонии у военнослужащих МО РФ. Методические указания. Москва, 2010.Kuchmin A.N., Akimkin V.G., Sinopalnikov A.I. et al. Diagnosis, treatment and prevention of community-acquired pneumonia in military personnel of the Ministry of Defense of the Russian Federation. Guidelines. Moscow, 2010. (In Russian).Овчинников Ю.В., Зайцев А.А., Синопальников А.И., Щеголев А.В. и др. Диагностика, лечение и вакцинопрофилактика внебольничной пневмонии у военнослужащих. Методические указания по лечению внебольничной пневмонии у военнослужащих. Москва, 2015.Ovchinnikov Yu.V., Zaitsev A.A., Sino palnikov A.I., Shchegolev A.V. et al. Diagnosis, treatment and vaccination of community–acquired pneumonia in military personnel. Guidelines for the treatment of community-acquired pneumonia in military personnel. Moscow, 2015. (In Russian).Приказ Министерства здравоохранения РФ от 10 мая 2017 г. № 203н «Об утверждении критериев оценки качества медицинской помощи». URL: https://www.garant.ru/hotlaw/federal/1111351/?Order of the Ministry of Health of the Russian Federation dated May 10, 2017 No. 203n “On approval of criteria for assessing the quality of medical care”. (In Russian). URL: https://www.garant.ru/hotlaw/federal/1111351/?Синопальников А.И., Зайцев А.А. Медленно разрешающаяся/ неразрешающаяся внебольничная пневмония. РМЖ. 2009;17(5): 361–367.Sinopaknikov A.I., Zaitsev A.A. Slow-re solving/non-resolving community-acquired pneumonia. RMG. 2009;17(5):361– 367. (In Russian).Athlin S., Lidman C., Lundqvist A. et al. Management of communityacquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect. Dis. 2018;50(4):247–272.Athlin S., Lidman C., Lundqvist A. et al. Management of communityacquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect. Dis. 2018;50(4):247–272.Carreno J., Lodise T. Ceftaroline fosamil for the treatment of commu nity-acquired pneumonia: from FOCUS to CAPTURE. Infect. Dis. Ther. 2014;3(2):123–132.Carreno J., Lodise T. Ceftaroline fosamil for the treatment of commu nity-acquired pneumonia: from FOCUS to CAPTURE. Infect. Dis. Ther. 2014;3(2):123–132.Charles P., Wolfe R., Whitby M. et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in com munity-acquired pneumonia. Clin. Infect. Dis. 2008;47(3):375– 384.Charles P., Wolfe R., Whitby M. et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in com munity-acquired pneumonia. Clin. Infect. Dis. 2008;47(3):375– 384.Claessens Y., Debray M., Tubach F. et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2015;192(8):974–982.Claessens Y., Debray M., Tubach F. et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2015;192(8):974–982.Cristinacce A., Wright J., Stone G. et al. A retrospective analysis of probability of target attainment in community-acquired pneumonia: ceftaroline fosamil versus comparators. Infect. Dis. Ther. 2019;8(2):185–198.Cristinacce A., Wright J., Stone G. et al. A retrospective analysis of probability of target attainment in community-acquired pneumonia: ceftaroline fosamil versus comparators. Infect. Dis. Ther. 2019;8(2):185–198.Ebell M., Bentivegna M., Cai X. et al. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a metaanalysis. Acad. Emerg. Med. 2020;27(3):195–206.Ebell M., Bentivegna M., Cai X. et al. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a metaanalysis. Acad. Emerg. Med. 2020;27(3):195–206.Fukuyama H., Ishida T., Tachibana H. et al. Validation of scoring systems for predicting severe community-acquired pneumonia. Intern. Med. 2011;50(18):1917–1922.Fukuyama H., Ishida T., Tachibana H. et al. Validation of scoring systems for predicting severe community-acquired pneumonia. Intern. Med. 2011;50(18):1917–1922.Grau S., Lozano V., Valladares A. et al. Antibiotic expected eff ectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain. Clinicoecon. Outcomes Res. 2014; 6:83–92.Grau S., Lozano V., Valladares A. et al. Antibiotic expected eff ectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain. Clinicoecon. Outcomes Res. 2014; 6:83–92.Guchev I., Kozlov R., Stratchounski L., Sinopalnikov A., Klochkov O., Yu V. Management of nonsevere pneumonia in military trainees with the urinary antigen test for streptococcus pneumoniae: an innovative approach to targeted therapy. Clinical Infectious Diseases. 2005;40(11):1608–1616.Guchev I., Kozlov R., Stratchounski L., Sinopalnikov A., Klochkov O., Yu V. Management of nonsevere pneumonia in military trainees with the urinary antigen test for streptococcus pneumoniae: an innovative approach to targeted therapy. Clinical Infectious Diseases. 2005;40(11):1608–1616.Horita N., Otsuka T, Haranaga S. et al. Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis. Respirology. 2016;1(7):1193–1200.Horita N., Otsuka T, Haranaga S. et al. Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis. Respirology. 2016;1(7):1193–1200.Johansson N., Kalin M., Backman-Johansson C. et al. Procalcitonin levels in community–acquired pneumonia — correlation with aetiology and severity. Scand. J. Infect. Dis. 2014;46(11):787–791.Johansson N., Kalin M., Backman-Johansson C. et al. Procalcitonin levels in community–acquired pneumonia — correlation with aetiology and severity. Scand. J. Infect. Dis. 2014;46(11):787–791.Lee J., Kim H., Kim Y. Is β-Lactam plus macrolide more eff ective than β-Lactam plus fl uoroquinolone among patients with severe community-acquired pneumonia? A systemic review and metaanalysis. J. Korean. Med. Sci. 2017;32(1):77–84.Lee J., Kim H., Kim Y. Is β-Lactam plus macrolide more eff ective than β-Lactam plus fl uoroquinolone among patients with severe community-acquired pneumonia? A systemic review and metaanalysis. J. Korean. Med. Sci. 2017;32(1):77–84.Lim W., Baudouin S., George R. et al. BTS guidelines for the management of community-acquired pneumonia in adults — update 2009. Thorax. 2009;64(S3):55.Lim W., Baudouin S., George R. et al. BTS guidelines for the management of community-acquired pneumonia in adults — update 2009. Thorax. 2009;64(S3):55.Llamas–Á lvarez A., Tenza-Lozano E., Latour–Pé rez J. et al. Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: systematic review and metaanalysis. Chest. 2017;151(2):374–382.Llamas–Á lvarez A., Tenza-Lozano E., Latour–Pé rez J. et al. Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: systematic review and metaanalysis. Chest. 2017;151(2):374–382.Metlay J., Waterer G., Long A. et al. Diagnosis and treatment of adults with community-acquired pneumonia. an offi cial clinical practice guideline of the American Thoracic Society and infectious diseases society of America. Am. J. Respir. Crit. Care Med. 2019;200:e45–e67.Metlay J., Waterer G., Long A. et al. Diagnosis and treatment of adults with community-acquired pneumonia. an offi cial clinical practice guideline of the American Thoracic Society and infectious diseases society of America. Am. J. Respir. Crit. Care Med. 2019;200:e45–e67.Nseir W., Farah R., Mograbi J., Makhoul N. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. J. Crit. Care. 2013;28(3):291–295.Nseir W., Farah R., Mograbi J., Makhoul N. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. J. Crit. Care. 2013;28(3):291–295.Ollivier J., Carrie C., d’Houdain N. et al. Are standard dosing regimens of ceftriaxone adapted for critically Ill patients with augmented creatinine clearance? Antimicrob. Agents Chemother. 2019;63(3):2134–2218.Ollivier J., Carrie C., d’Houdain N. et al. Are standard dosing regimens of ceftriaxone adapted for critically Ill patients with augmented creatinine clearance? Antimicrob. Agents Chemother. 2019;63(3):2134–2218.Rachina S., Zakharenkov I., Dekhnich N. et al. Aetiology of severe community-acquired pneumonia and antimicrobial resistance of Steptococcus pneumoniae in adults in Russia. J. Antimicrob. Chemother. 2021;6(5):1368–1370.Rachina S., Zakharenkov I., Dekhnich N. et al. Aetiology of severe community-acquired pneumonia and antimicrobial resistance of Steptococcus pneumoniae in adults in Russia. J. Antimicrob. Chemother. 2021;6(5):1368–1370.Sligl W., Asadi L., Eurich D. et al. Macrolides and mortality in critically Ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit. Care Med. 2014;42(2):420–432.Sligl W., Asadi L., Eurich D. et al. Macrolides and mortality in critically Ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit. Care Med. 2014;42(2):420–432.Torres A., Blasi F., Peetermans W. et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur. J. Clin. Microbiol. Infect. Dis. 2014;33(7):1065–79.Torres A., Blasi F., Peetermans W. et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur. J. Clin. Microbiol. Infect. Dis. 2014;33(7):1065–79.Niederman M. Cilloniz C. Aspiration pneumonia. Rev. Esp. Quimioter. 2022;35(1):73–77Niederman M. Cilloniz C. Aspiration pneumonia. Rev. Esp. Quimioter. 2022;35(1):73–77Yang T. Baloxavir Marboxil: The First Cap–Dependent Endonuclease Inhibitor for the Treatment of Influenza. Pharmacother. 2019;53(7):754–759.Yang T. Baloxavir Marboxil: The First Cap–Dependent Endonuclease Inhibitor for the Treatment of Influenza. Pharmacother. 2019;53(7):754–759.

The authors declare that there are no conflicts of interest present.